Rvl Pharmaceuticals Plc

Entity > Corporation > US > New York City New York > Rvl Pharmaceuticals Plc

About Rvl Pharmaceuticals Plc

RVL Pharmaceuticals is a specialty pharmaceutical company specialising in the development and commercialization of ophthalmic and medical aesthetics products. The first FDA-approved ophthalmic product is the foundation of our unwavering commitment to improving patients' lives.

Focus on Eyecare and Medical Aesthetics: RVL Pharmaceuticals specializes in the development and commercialization of products in the eyecare and medical aesthetics sectors. The company aims to address the specific needs of these markets by offering innovative solutions.

Commercialization of UPNEEQ®: RVL Pharmaceuticals plc is primarily focused on the commercialization of UPNEEQ® (oxymetazoline hydrochloride). UPNEEQ® is a product that targets certain eye conditions and is used to treat symptoms such as redness and irritation.

Strategic Partnership with Revision Skincare®: In 2022, RVL Pharmaceuticals announced a strategic partnership with Revision Skincare®. This partnership aims to leverage the strengths of both companies to enhance the commercialization of UPNEEQ® and provide comprehensive skincare solutions.

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Rvl Pharmaceuticals Plc

Company Attribute Value
Address StreetAddress: 400 Crossing Blvd, AddressLocality: Bridgewater, AddressRegion: New Jersey, PostalCode: 8807, AddressCountry: United States
Name Rvl Pharmaceuticals Plc
Number Of Employees 156
Revenue $17,501,000 USD
Url rvlpharma
Google google

Rvl Pharmaceuticals Plc


New York City, US
20 Feb 2024

New York City, US
20 Feb 2024

Rvl Pharmaceuticals Plc

Page: 1 Desktop | Laptop Devices

RVL Pharmaceuticals
RVL Pharmaceuticals
https://finance.yahoo.com › news › rvl-pharmaceuticals-...
RVL Pharmaceuticals plc Announces Prepackaged ...
https://ir.osmotica.com › press-releases
Press Releases | RVL Pharmaceuticals
https://www.wsj.com › articles › rvl-pharmaceuticals-sub...
RVL Pharmaceuticals Subsidiaries File for Bankruptcy
RVL Pharma (@RVLPharma) / X
https://www.annualreports.com › Company › rlv-pharma...
RVL Pharmaceuticals plc
Related Searches
Related Searches
Rvl pharmaceuticals plc stock price
Who owns rvl pharmaceuticals plc
Rvl pharmaceuticals plc stock
Knowledge Panel
Knowledge Panel

RVL Pharmaceuticals PLC (Pharmaceutical company)


RVL Pharmaceuticals plc (formerly Osmotica Pharmaceuticals plc) is a specialty pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas.

  • Stock price : RVLPQ (OTCMKTS) $0.00 0.00 (0.00%)Feb 16, 4:00 PM EST - Disclaimer
  • Subsidiaries : Rvl Pharmaceuticals Inc., Osmotica Pharmaceutical Us LLC, Osmotica Holdings S.C.Sp.
  • Headquarters : Bridgewater, NJ

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 194178